Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Hepatitis C treatment may cause frontal fibrosing alopecia.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Baricitinib successfully treated severe hair loss.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

More research needed to confirm finasteride as standard treatment for FFA.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Ruxolitinib cream may help treat severe hair loss in children.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

QLT0267 stops hair follicle cell growth and movement.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Targeting EGFR may help reduce hair loss from chemotherapy.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Erlotinib can cause persistent excessive hair growth.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.